Comprehensive Support: Nuforms physicians provide ongoing support, ensuring patients diets, exercise, and lifestyle routines are optimized for sustained weight management
Average weight loss after 48 weeks included: 1 mg dose: about 8.7% body-weight reduction 4 mg dose: about 17.1% reduction 8 mg dose: about 22.8% reduction 12 mg dose: about 24.2% reduction Placebo: about 2.1% reduction These results represented one of the largest average weight reductions reported for an antiobesity medication in a randomized clinical trial
The app also connects you with a community of peers, providing a platform for sharing experiences and motivation
Although there is no data in humans, GLP-1RAs should not be used in patients with a past or family history of medullary thyroid cancer or in patients with multiple endocrine neoplasia type 2
The withdrawal pattern typically involves gradual return of appetite over 2 to 4 weeks, followed by weight regain over the subsequent months
the risks are often ignored and downplayed, but can be quite serious such as stomach paralysis and other organ damage plus a lifelong reliance on these medicines to keep weight loss maintained